Physician profile
Daniel C Rohrer
NPI 1154390482
$779.82
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $303 · 2020: $49.78 · 2021: $14.96 · 2022: $412.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Providence Medical Technology, INC. | $189.20 | 2022 | |
| Zimmer Biomet Holdings, INC. | $145.34 | 2019-2020 | |
| Globus Medical, INC. | $138.70 | 2019-2022 | |
| Elekta, INC. | $111.86 | 2022 | |
| Lilly USA, LLC | $45.26 | 2019-2020 | |
| Abbott Laboratories | $39.19 | 2022 | |
| Intrinsic Therapeutics | $38.19 | 2022 | |
| Stryker Corporation | $24.37 | 2020 | |
| Ucb, INC. | $20.70 | 2022 | |
| Boston Scientific Corporation | $14.08 | 2019 | |
| Medtronic USA, INC. | $12.93 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Rohrer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.